Zacks: Brokerages Set $5.30 Price Target for Catasys, Inc. (CATS)

Catasys, Inc. (NASDAQ:CATS) has received a consensus broker rating score of 2.00 (Buy) from the one brokers that provide coverage for the stock, Zacks Investment Research reports. One research analyst has rated the stock with a buy rating. Catasys’ rating score has declined by 33.3% in the last three months as a result of a number of analysts’ upgrades and downgrades.

Brokers have set a twelve-month consensus price target of $5.30 for the company and are expecting that the company will post ($0.22) earnings per share for the current quarter, according to Zacks. Zacks has also assigned Catasys an industry rank of 93 out of 265 based on the ratings given to its competitors.

Separately, Zacks Investment Research upgraded shares of Catasys from a “sell” rating to a “hold” rating in a research report on Thursday, February 8th.

An institutional investor recently bought a new position in Catasys stock. Weber Alan W purchased a new position in shares of Catasys, Inc. (NASDAQ:CATS) in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor purchased 108,165 shares of the company’s stock, valued at approximately $406,000. Weber Alan W owned about 0.68% of Catasys as of its most recent SEC filing. Hedge funds and other institutional investors own 4.68% of the company’s stock.

Shares of Catasys (CATS) traded down $0.06 during trading on Thursday, hitting $4.77. 49,943 shares of the company’s stock were exchanged, compared to its average volume of 74,825. Catasys has a 1-year low of $3.30 and a 1-year high of $14.00. The firm has a market capitalization of $74.63, a P/E ratio of -2.78 and a beta of 0.18.

Catasys (NASDAQ:CATS) last released its quarterly earnings results on Wednesday, March 7th. The company reported ($0.17) earnings per share for the quarter, missing the consensus estimate of ($0.09) by ($0.08). The company had revenue of $3.04 million for the quarter, compared to analysts’ expectations of $3.00 million. analysts expect that Catasys will post -0.58 earnings per share for the current year.

ILLEGAL ACTIVITY NOTICE: This report was first published by The Ledger Gazette and is the property of of The Ledger Gazette. If you are accessing this report on another domain, it was illegally copied and republished in violation of US and international trademark & copyright legislation. The correct version of this report can be viewed at

Catasys Company Profile

Catasys, Inc provides data analytics based specialized behavioral health management and integrated treatment services to health plans and other third party payors. It offers OnTrak solution to improve treatment outcomes and lower the utilization of medical and behavioral health plan services. The company’s OnTrak solution includes medical and psychosocial interventions; and a proprietary Web based clinical information platform and database, psychosocial programs, and integrated care coaching services.

Get a free copy of the Zacks research report on Catasys (CATS)

For more information about research offerings from Zacks Investment Research, visit

Receive News & Ratings for Catasys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Catasys and related companies with's FREE daily email newsletter.

Leave a Reply